Cauti Filippo Maria, O'Mahony Constantinos, Pantazis Antonis
Cardiology Department, University of Rome Sapienza, Rome, Italy.
BMJ Case Rep. 2010 Aug 24;2010:bcr0220102760. doi: 10.1136/bcr.02.2010.2760.
A normotensive 50-year-old man was evaluated for cardiac symptoms associated with left ventricular hypertrophy (LFH). His symptoms were caused by cardiac involvement from Anderson-Fabry disease (AFD), an X linked lysosomal storage disease caused by mutations in the GLA gene which encodes for the lysosomal enzyme -galactosidase A. He was treated with recombinant enzyme but the clinical course was complicated by arrhythmias and the patient required an internal cardioverter defibrillator. Even though AFD is rare, this case illustrates the importance of considering the diagnosis in selected patients as effective treatment has recently become available. Recognition of AFD also allows for screening of asymptomatic relatives who may benefit from treatment before irreversible life-threatening complications develop.
一名血压正常的50岁男性因与左心室肥厚(LVH)相关的心脏症状接受评估。他的症状由安德森 - 法布里病(AFD)累及心脏所致,AFD是一种X连锁溶酶体贮积病,由编码溶酶体酶α - 半乳糖苷酶A的GLA基因突变引起。他接受了重组酶治疗,但临床过程因心律失常而复杂化,患者需要植入体内除颤器。尽管AFD罕见,但该病例说明了在特定患者中考虑诊断的重要性,因为最近已有有效的治疗方法。认识AFD还能对无症状亲属进行筛查,他们可能在出现不可逆的危及生命的并发症之前从治疗中获益。